SHZ Healthcare Drug Manufacturers - Specialty & Generic 000538.SZ

Yunnan Baiyao Group Co.,Ltd

$ 48.43 -0.98 %

Operating globally and domestically within China, Yunnan Baiyao Group Co., Ltd. specializes in the pharmaceutical industry. Its diverse portfolio encompasses health supplements, a wide array of medications, medical devices, traditional Chinese medicine ingredients, and even tea. These offerings are marketed under various brand identities, including Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong. The company, established in 1902, maintains its principal offices in Kunming, China.

CEO: Ming Dong - https://www.yunnanbaiyao.com.cn

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

-

Recommandation

-

DCF

$ 86.21

Loading data...

000538.SZ vs S&P500

Loading data...

No data available.

Quick ratio

2.27

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

16.42

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

2.95

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

12.96 %

reflects reasonable profitability, showing good use of equity.

ROIC

11.32 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

5.17

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.05

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

2.55

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

76.66 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
5 indicates moderate financial health
Altman score
5.63 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.70 indicates that the company has a moderate ability to cover its short-term debts with its cash
Debt Ratio
0.04 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.